Michelle A. Hodges - 27 May 2022 Form 4 Insider Report for QUIDEL CORP /DE/ (QDEL)

Role
SVP, General Counsel
Signature
/s/ Phillip S. Askim, attorney-in-fact for Michelle A. Hodges
Issuer symbol
QDEL
Transactions as of
27 May 2022
Net transactions value
$0
Form type
4
Filing time
01 Jun 2022, 16:25:13 UTC
Previous filing
26 May 2022
Next filing
17 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QDEL Common Stock Disposed to Issuer -708 -100% 0 27 May 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QDEL Non-Qualified Stock Options Disposed to Issuer $0 -2,105 -100% $0.000000* 0 27 May 2022 Common Stock 2,105 $188.95 Direct F2, F3
transaction QDEL Non-Qualified Stock Options Disposed to Issuer $0 -1,892 -100% $0.000000* 0 27 May 2022 Common Stock 1,892 $254.00 Direct F2, F4
transaction QDEL Non-Qualified Stock Options Disposed to Issuer $0 -6,438 -100% $0.000000* 0 27 May 2022 Common Stock 6,438 $103.36 Direct F2, F5
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -714 -100% $0.000000* 0 27 May 2022 Common Stock 714 Direct F6, F7, F8
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -1,420 -100% $0.000000* 0 27 May 2022 Common Stock 1,420 Direct F6, F7, F9
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -1,260 -100% $0.000000* 0 27 May 2022 Common Stock 1,260 Direct F6, F7, F10
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -1,559 -100% $0.000000* 0 27 May 2022 Common Stock 1,559 Direct F6, F7, F11
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -11,910 -100% $0.000000* 0 27 May 2022 Common Stock 11,910 Direct F6, F7, F12
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -6,439 -100% $0.000000* 0 27 May 2022 Common Stock 6,439 Direct F6, F7, F13
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -7,256 -100% $0.000000* 0 27 May 2022 Common Stock 7,256 Direct F6, F7, F14
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -1,020 -100% $0.000000* 0 27 May 2022 Common Stock 1,020 Direct F6, F7, F15
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -204 -100% $0.000000* 0 27 May 2022 Common Stock 204 Direct F6, F7, F15, F16
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Michelle A. Hodges is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho.
F2 Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
F3 1,052 shares will vest on December 1, 2022; 526 shares will vest on December 1, 2023; and 527 shares will vest on December 1, 2024.
F4 473 shares are vested in full; the remaining 1,419 shares will vest in equal installments on February 1, 2023, February 1, 2024 and February 1, 2025.
F5 1,609 shares will vest on each of January 31, 2023 and January 31, 2024; 1,610 shares will vest on each of January 31, 2025 and January 31, 2026.
F6 Each restricted stock unit represents the right to receive one share of Quidel common stock.
F7 Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
F8 714 shares will vest in equal installments on December 1, 2022, December 1, 2023 and December 1, 2024.
F9 473 shares will vest on each of February 1, 2023 and February 1, 2024; 474 shares will vest on February 1, 2025.
F10 1,260 shares will vest in equal installments on May 25, 2023, May 25, 2024 and May 25, 2025.
F11 389 shares will vest on October 15, 2022; the remaining 1,170 shares will vest in equal installments on October 15, 2023, October 15, 2024 and October 15, 2025.
F12 11,910 shares will vest in equal installments on November 8, 2022, November 8, 2023 and November 8, 2024.
F13 1,609 shares will vest on January 31, 2023; the remaining 4,830 shares will vest in equal installments on January 31, 2024, January 31, 2025 and January 31, 2026.
F14 3,628 shares will vest on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026.
F15 Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
F16 204 shares will vest on January 31, 2023.